Diabetes, Vol 48, Issue 11 2145-2149, Copyright © 1999 by American Diabetes Association
Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity
JJ Couper, C Steele, S Beresford, T Powell, K McCaul, A Pollard, S Gellert, B Tait, LC Harrison and PG Colman
Department of Endocrinology, Women's and Children's Hospital, North Adelaide SA, Australia. jcouper@medicine.adelaide.edu.au
The hypothesis that early exposure to cow's milk or lack of breast-feeding
predisposes to type 1 diabetes remains controversial. We aimed to determine
prospectively the relationship of, first, duration of exclusive
breast-feeding and total duration of breast-feeding, and second,
introduction of cow's milk protein as infant formula, cow's milk, or dairy
products, to the development of islet antibodies in early life. Some 317
children with a first-degree relative with type 1 diabetes were followed
prospectively from birth for 29 months (4-73). Mothers kept a home diary
and answered infant feeding questionnaires at 6-month intervals. No
systematic feeding advice was given. Insulin autoantibodies (normal range
<5.5%), anti-GAD antibodies (<5.0 U), and anti-IA2 antibodies
(<3.0 U) were measured at 6-month intervals. Cox proportional hazards
model of survival analysis detected no significant difference between
children who did not develop islet antibodies (225 of 317 [71%]), children
with one islet antibody raised once (52 of 317 [16.4%]), children with one
antibody raised repeatedly (18 of 317 [5.7%]), or children with two or more
antibodies raised (22 of 317 [6.9%]), in terms of duration of exclusive
breast-feeding, total duration of breast-feeding, or introduction of cow's
milk-based infant formulas, cow's milk, or dairy products (relative risk:
0.91-1.09). Four of the children with two or more islet antibodies
developed type 1 diabetes. We conclude that there is no prospective
association between duration of breast-feeding or introduction of cow's
milk and the development of islet autoimmunity in high-risk children.